Scientists shed light on mystery surrounding hepatitis B virus: Discovery is decades in the making
(Medical Xpress)—Scientists from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, and the University of Oxford, U.K., have shed light on a long-standing ...
Medical research
Jan 09, 2013 |
not rated yet |
0
Team discovers new gene that affects clearance of hepatitis C virus
(Medical Xpress)—Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts ...
Genetics
Jan 08, 2013 |
5 / 5 (1) |
0
|
Sustained virological response linked with improved survival for patients with chronic HCV infection
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...
Diseases, Conditions, Syndromes
Dec 25, 2012 |
5 / 5 (1) |
0
|
Researchers discover how hepatitis C virus reprograms human liver cells
Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds ...
Diseases, Conditions, Syndromes
Dec 18, 2012 |
5 / 5 (5) |
0
|
Most people with hepatitis C go untreated, despite effective drugs
Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Ho ...
Diseases, Conditions, Syndromes
Dec 10, 2012 |
not rated yet |
0
Molecular root of 'exhausted' T cells in chronic viral infection
When you get an acute infection, such as influenza, the body generally responds with a coordinated response of immune-cell proliferation and attack that rapidly clears the pathogen. Then, their mission done, the immune system ...
Medical research
Nov 29, 2012 |
5 / 5 (2) |
0
|
Survival gene may be key to controlling HIV and hepatitis
(Medical Xpress)—A newly discovered gene that is essential for embryo survival could also hold the key to treating and potentially controlling chronic infections such as HIV, hepatitis and tuberculosis.
Immunology
Nov 26, 2012 |
5 / 5 (3) |
0
|
Beginning of the end of hepatitis B in Australia?
(Medical Xpress)—A newborn vaccination program first introduced for Aboriginal babies in the Northern Territory has made significant inroads, significantly helping in the push to eradicate chronic hepatitis ...
Diseases, Conditions, Syndromes
Nov 14, 2012 |
not rated yet |
0
Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Op ...
Diseases, Conditions, Syndromes
Oct 22, 2012 |
5 / 5 (1) |
0
Blocking tumor-induced inflammation impacts cancer development
Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their ...
Cancer
Oct 03, 2012 |
5 / 5 (2) |
0
|
Follow-up lacking for babies after hepatitis B vaccination: CDC
(HealthDay)—Many U.S. babies born to mothers infected with hepatitis B do not receive recommended follow-up testing after vaccination, a new study finds.
Diseases, Conditions, Syndromes
Sep 27, 2012 |
not rated yet |
0
Treating hepatitis C infection in prison is good public policy
Incarcerated patients with chronic hepatitis C virus (HCV) infection are just as likely to respond to treatment for the disease as patients in the community, according to findings published in the October issue of Hepatology, a peer ...
Diseases, Conditions, Syndromes
Sep 27, 2012 |
not rated yet |
0
Telaprevir: Added benefit in certain patients with hepatitis C
The drug telaprevir (trade name: Incivo) has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for ...
Diseases, Conditions, Syndromes
Sep 05, 2012 |
not rated yet |
0
Molecular and protein markers discovered for liver transplant failure from hepatitis C
Researchers have discovered molecular and protein signatures that predict rapid onset of liver damage in hepatitis C patients following a liver transplant. The markers appeared soon after transplant and well before clinical ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
|
Immune responses can be generated locally within human melanoma skin metastases
In many types of cancer, activated immune cells infiltrate the tumor and influence clinical outcome. It is not always clear where these cells are activated, but results reported in Cancer Research, a journal of the Americ ...
Cancer
Jul 31, 2012 |
not rated yet |
0
|
